EPOCH BIODESIGN LTD

Company number 11824812 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£25,006,974

Balance sheet as at 2025-03-31

View full accounts →

What it does

Research and experimental development on biotechnology

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2019-02-13
Employees
27 (2025 accounts · was 25 in 2024)
Registered office
10 Finsbury Square, London, England, EC2A 1AJ
Postcode
EC2A 1AJ
Capital
272 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-03-31
Next due by
2026-12-31
Financial year end
31 March

Confirmation statement

Last statement dated
2026-02-12
Next due by
2027-02-26
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 2 current · 2 resigned

Clay DUMAS Director
Appointed 2021-12-14
Appointed 2019-02-13

View all officers and resignations →

Contact details

Website
epochbiodesign.com
Phone
03031231113

Epoch Biodesign produces virgin-quality recycled polymer with ultra-low emissions, starting with nylon 6,6.‍ This is Forever Recycling.

Previous company names

NameDate changed
MELLIZYME BIOTECHNOLOGY LIMITED2023-02-15

Previous registered addresses 1

AddressChanged on
12 NICHOLAS STREET, CHESTER, CHESHIRE, CH1 2NX, UNITED KINGDOM2019-03-22

Among its peers

Top 5%

by shareholders' funds, of 138 similar companies in EC

Among the biggest employers among its local peers (27 staff).

Trading since 2019.

No.2 of the largest research and experimental development on biotechnology companies in London →

Competitors London

This company ranks 2 among research and experimental development on biotechnology in London.

Full league table →

The class of 2019

39%

of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →